Published in:
Open Access
01-12-2020 | Acute Kidney Injury | Letter
Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
Authors:
Patrick M. Honore, Leonel Barreto Gutierrez, Luc Kugener, Sebastien Redant, Rachid Attou, Andrea Gallerani, David De Bels
Published in:
Critical Care
|
Issue 1/2020
Login to get access
Excerpt
We read with great interest the article by Björck et al. who concluded that in their study of critically ill patients with invasive group A streptococcal (iGAS) infections, emm1/T1 was the most dominant serotype and that patients with that serotype demonstrated more circulatory and renal failure than patients with other serotypes of iGAS [
1]. We would like to make some comments. Intravenous immunoglobulins (IVIGs) are often used as a part of the treatment of iGAS [
1]. We noted that 52% of the emm1/T1 serotype patients received IVIGs as compared to 28% of the patients with other serotypes [
1]. The incidence of acute kidney injury (AKI) with IVIGs stabilized with glucose, maltose,
d-sorbitol, mannitol, glycine, or
l-proline has been found to be lower than that with sucrose-stabilized products [
2]. AKI induced by sucrose-containing IVIGs is likely related to the toxic action of sucrose on the nephron, whereby excess sucrose in the kidney causes osmotic nephrosis [
2,
3]. Whilst osmotic nephrosis has been reported with sucrose-free IVIGs, the incidence is much lower because the levels of these agents can be closely regulated by enzymes within the kidney [
2,
4]. Similarly to sucrose, excessive glucose accumulation can have deleterious effects on the proximal tubules [
5] and, since intravenous glucose infusion is known to produce a rapid increase in blood glucose and insulin levels in normal subjects, diabetic patients are at particular risk of AKI following administration of glucose-stabilized IVIGs [
2]. The incidence of diabetes mellitus is not reported in the paper of Björck et al. [
1]. It is possible that the increase of AKI in the emm1/T1 serotype group was due to IVIGs. It would be very interesting to know if the IVIGs given to patients in this study were sucrose-stabilized. …